The transformation-associated region of herpesvirus saimiri strains is variable, whereas other parts of the virus genome are highly conserved. However, we observed considerable interstrain sequence divergence of the early viral regulatory orf50 gene, which encodes the R transactivator, a homolog of Epstein-Barr virus BRLF1. The orf50 gene of strain C488 was transcribed at low abundance during lytic infection, whereas antisense transcripts were simultaneously expressed at high levels. A spliced variant, orf50a, was detectable by RT-PCR and RNase protection assays in stimulated C488-transformed, nonpermissive human T cells. In contrast to strain A11, the short, unspliced orf50b form of C488 displayed complete transactivation capability on the orf6 and orf57 promoters. In summary, there are unexpected structural and functional differences between the orf50 genes of herpesvirus saimiri strains, which differ in their capability to transform human T lymphocytes.
INTRODUCTION
Squirrel monkeys (Saimiri sciureus) are naturally and persistently infected by herpesvirus saimiri (HVS; saimiriine herpesvirus type 2), a ␥ 2 -herpesvirus which does not cause any disease in this host. However, if the virus is experimentally transferred to other New World primates, including common marmosets (Callithrix jacchus) or cottontop tamarins (Saguinus oedipus), the animals develop acute T-cell lymphoma within a few weeks. HVS strains have been assigned to three subgroups, A, B, and C, depending on the transforming and pathogenic capability and sequence divergence of a terminal region of the viral L-DNA (Medveczky et al., 1984 (Medveczky et al., , 1989 . In strain 11 of subgroup A, the gene for the saimiri-transforming protein (stpA) was identified in this terminal position. Deletion of this gene rendered the virus nonpathogenic and nontransforming (Desrosiers et al., , 1985 (Desrosiers et al., , 1986 Koomey et al., 1984) . The virus strain 488 of subgroup C carries two genes at this position: stpC and a gene coding for the tyrosine kinase interacting protein (Tip), which interacts with the T-cellular protein kinase Lck (Biesinger et al., 1990 (Biesinger et al., , 1995 . Both stpA and stpC have been shown to encode transforming proteins (Jung et al., 1991) . In contrast to virus strain A11, C488 is capable of transforming human T cells to stable growth in culture . In these cells, the virus persists episomally without virion production and with restricted virus gene ex-pression Fickenscher et al., 1996; Knappe et al., 1997) . Deletion of stpC and tip of C488 abolishes the transforming capability for human and simian T cells, and the induction of T-cell lymphoma in common marmosets Duboise et al., 1998a) . The rest of the virus genome was assumed to be highly conserved among different virus strains (Medveczky et al., 1984 (Medveczky et al., , 1989 . For example, sequence analysis of a 16-kb gene block from orf12 to orf25 of C488 revealed a high degree of conservation, ranging from 85 to 99% amino acid identity (Albrecht et al., 1992; Knappe et al., 1997) . However, only virus strain A11 has been entirely sequenced (Albrecht et al., 1992) .
Besides the transforming genes stpC and tip of C488, we were interested in the viral regulatory genes and their role in virus replication and T-cell transformation. There are only three likely candidates for genes which might regulate replication in HVS (Nicholas et al., 1990 (Nicholas et al., , 1991 . The first is the major immediate-early gene orf14, which is highly conserved between A11 and C488 (95%); orf14 is the third transformation-associated virus gene in transformed human T cells and encodes a superantigen-homologous mitogen for T cells (Yao et al., 1996) . This gene is dispensable for virus replication in vitro and in cottontop tamarins, and is probably unrelated to replication regulation (Nicholas et al., 1990; Knappe et al., 1997; Duboise et al., 1998b) . Moreover, deletion of this gene did not affect the transformation of human T cells. Its role in transformation of simian T cells and pathogenicity is variable, depending on the primate species analyzed (Knappe et al., , 1998 Duboise et al., 1998b) . The second immediate-early gene (orf57) is conserved at the amino acid level (Nicholas et al., 1990; Knappe et al., 1997) . In transformed human T cells, weak transcription was detectable after phorbolester stimulation ; orf57 is homologous to IE63/ICP27 of herpes simplex virus, and has been shown to redistribute spliceosome components and to suppress the expression of spliced viral transcripts (Whitehouse et al., 1998b; Cooper et al., 1999) .
The third viral regulatory gene candidate is the early gene orf50, which encodes a transactivator related to the BRLF1 product Rta of Epstein-Barr virus (EBV). The orf50 gene product of strain A11 has been shown to transactivate delayed-early virus promoters and to activate transcription of the orf57 splicing regulator gene. Two different mRNAs are transcribed from the orf50 gene: a long, spliced transcript (orf50a), which can be detected early in infection and causes strong transactivation, and a shorter, unspliced transcript (orf50b), which only weakly transactivates promoters of other HVS genes (Nicholas et al., 1991; Whitehouse et al., 1997a Whitehouse et al., ,b, 1998a .
In this study, we performed a structural and functional analysis of the orf50 gene of strain C488, which is capable of transforming human T cells in culture. Unexpectedly, we observed a marked sequence divergence in the orf50 gene between virus strains A11 and C488. This genomic region was found to be heavily transcribed during replication, predominantly in the antisense orientation. In transformed human T lymphocytes, we showed that orf50 is inducibly transcribed after phorbolester stimulation. In addition, the observed sequence divergence results in proteins with altered transactivation properties, which seem to assign the dominant regulatory function to orf50b in strain C488.
RESULTS

Sequence divergence between the orf50 genes of HVS strains C488 and A11
The genomic orf50 region of the virus strain C488 was sequenced from a library of overlapping HindIII and XbaI fragment plasmids , resulting in a 3171-nucleotide (nt) sequence named 488R. Sequence comparison of the C488 and A11 orf50 regions revealed a considerable divergence between strains C488 and A11 (Table 1, Fig. 1 ). However, the overall gene structure was preserved. The predicted spliced structure of orf50a was confirmed by RT-PCR (primers HF317/HF377) and cDNA sequencing, using RNA from infected OMK cells. Whereas ORF49 was conserved to 95% at amino acid level, only 60% identity was observed for the whole ORF50b. When the 250 C-terminal amino acids of the ORF50b were compared separately, the identity was only 49%. The degree of conservation is similar between both HVS strains and herpesvirus ateles. However, the respective proteins of rhesus monkey rhadinovirus, human herpesvirus type 8, and EBV are only distantly related (Fig. 1C ).
Strain A11 ORF50b has potential start codons at nt positions (pos.) 71188 and 71353. In strain C488, the first initiation codon is missing, whereas the second is conserved at pos. 1638 (488R). In vitro transcription and translation experiments using T7 polymerase and reticulocyte lysates demonstrated a protein of approximately 64 kDa derived from the spliced orf50a cDNA (predicted size: 58 kDa). In addition, a smaller protein was produced, with both the spliced orf50a cDNA plasmid and with a genomic clone of orf50b (Fig. 2) . The apparent protein size of 45 kDa (predicted size: 38 kDa) is compatible with the putative start site at pos. 1638 in 488R, corresponding to pos. 71353 in A11.
Transcription of the orf50 region of C488
Transcription of the C488 orf50 region was studied after infection of OMK cells at a multiplicity of infection (m.o.i.) of approximately 4. Total cellular RNA was harvested at 8, 24, or 48 h after infection. At 72 h postinfection, the cytopathogenic effect had already led to significant loss of cells and poor RNA yields. Northern blot hybridization with a random-primed, double-stranded DNA probe for orf50b (pos. 982 to 2902 in 488R) demonstrated strong signals at unexpected band sizes of about 5.0, 3.7, and 2.9 kb, mainly at 48 h postinfection ( Fig. 3A) . Rehybridization with an in vitro transcribed, singlestranded antisense riboprobe of orf50b yielded extremely weak signals of about 1.2, 1.6, and 1.9 kb, which were confirmed by probing a blot carrying purified polyadenylated RNA (Fig. 3B ). On rehybridization using a sense-oriented, single-stranded orf50b RNA probe, the hybridization patterns with the double-stranded DNA probe were confirmed ( Fig. 3C ), which indicates that most transcripts from this region are oriented in the antisense direction with respect to orf50.
To further analyze transcription of the orf50 region, RT-PCR experiments were designed to amplify the 5Ј ends of transcripts. Initial experiments used a published tailing method (Whitehouse et al., 1997a) with primer HF184, which is directed upstream and binds to the central portion of orf50b. Two main PCR product species were generated which hybridized to a double-stranded orf50b DNA probe (data not shown). The pattern seemed similar to the observations made previously for strain A11 (Whitehouse et al., 1997a) . However, sequencing revealed that the larger product represented an unspliced fragment starting downstream of orf50a exon 1. The smaller product represented a spliced version with a large gap within orf50a exon 2, and thus did not correspond to the expected splicing pattern, suggesting that it may represent the antisense transcripts.
Therefore, further experiments for the rapid amplification of cDNA ends (RACE) were performed with additional primers and an improved protocol (Marathon, Clontech). In 5Ј and 3Ј RACE experiments, four different virus-specific primers were used (HF177, HF181, HF184, and HF653). Twenty-three representative cDNA clones were sequenced (Fig. 4 ). In the first part of the experi- The orf50 region nucleotide sequences of both virus strains (C488: 488R/AJ131935; A11: X64346) were aligned with the GCG programs bestfit, pileup, and plot similarity. The graph represents the local homology, when flanking stretches of 200 nt were tested. (B) The ORF50b amino acid sequences of strain C488 (upper) and A11 (lower) were aligned using the GCG program gap. Whereas there is high sequence conservation within the first 100 amino acids, the remaining part of the protein is much more divergent. (C) The ORF50 proteins and their homologs of other gammaherpesviruses were compared using the GCG program gap. The sequence identity (id%) and similarity (sim%) values are given, when ORF50a/ C488 was compared to the respective proteins derived from the sequences of HVS A11 (X64346), herpesvirus ateles (HVA; AF083424), rhesus monkey rhadinovirus (RRV; AF083501), human herpesvirus type 8 (HHV8; U75698), and human Epstein-Barr virus (EBV; V01555).
FIG. 2.
In vitro translation products of orf50. The products of in vitro transcription/translation reactions using T7 polymerase and reticulocyte lysates were separated on an SDS/polyacrylamide (12%) gel and subjected to autoradiography. Plasmid p50a contains the spliced cDNA of orf50a. Plasmid p50b harbors orf50b together with its native promoter. A major band of about 64 kDa (predicted size: 58 kDa) is generated by p50a. A minor band of about 45 kDa (predicted size: 38 kDa) is identical for p50a and p50b and argues for the usage of the common start codon at pos. 1638 in 488R. M, marker. ment, RNA from lytically infected OMK cells was used. Two of the 5Ј RACE clones (1, spliced; 2, unspliced) carried a polyT stretch at their 5Ј ends, suggesting that these transcripts had an antisense orientation to orf50 and served orf49. Clones 1 and 2 were identical to the cDNAs previously obtained by the tailing strategy. The 3Ј RACE clones 6 and 7 confirmed the presence of a splice acceptor site within exon 2 of orf50a. The respective splice donor sites and cDNA termini were localized further downstream, corresponding to orf52 and orf53. Moreover, the 3Ј RACE clones 11 and 12 indicated that there were also unspliced transcripts present of the same orf49 mRNA familiy. Some other unspliced cDNA clones also seemed to serve orf49 (e.g., 8 and 9). A few of the unspliced cDNA clones might theoretically encode orf50b (e.g., 4, 5, and 13). However, as no 3Ј polyA stretches were attached, it is more likely, that most of these cDNA clones represented antisense transcripts to orf50. This is compatible with the observation that Northern blot signals for orf50 were far weaker as compared to the antisense transcripts.
In additional 5Ј RACE experiments, RNA was utilized from transformed human T cells (CB-15) which had been stimulated with phorbolester (tetradecanoyl phorbol acetate [TPA], 2 ng/ml for 6 h) Fickenscher et al., 1996; Knappe et al., 1997; Fickenscher and Fleckenstein, 1998) . The resulting cDNA clones 16 and 17 showed the expected splice pattern for orf50a. Clones 21-23 corresponded to the described position of the orf50b promoter (Whitehouse et al., 1997a) . Three other cDNA clones (18) (19) (20) suggested an additional promoter near the start of exon2. These cDNAs have the coding capacity for orf50b, since there is no further initiation codon present upstream of pos. 1638. Antisense transcripts were not detectable in nonpermissive, transformed human T cells. The three groups of cDNAs correspond well to the three orf50 transcripts of 1.2, 1.6, and 1.9 kb observed during lytic replication (Fig. 3B ).
Transcription of orf50a during lytic replication and in transformed human T cells
Because the cDNA cloning experiments revealed a complex transcription pattern, orf50a transcription was specifically analyzed by RT-PCR, using the predicted splicing pattern (Whitehouse et al., 1997a) . As an internal control, RT-PCR for glyceroyl aldehyde phosphate dehydrogenase (gapdh) was performed. The 5Ј primers HF317 (C488) and HF463 (A11) are situated within exon 1 of orf50a, whereas the 3Ј primers HF182 (C488) and HF464 (A11) are located in the second exon. The kinetics of orf50a expression were studied after infection of OMK cells by HVS C488 or A11 at m.o.i. of approximately 4. Transcripts of orf50a were detectable starting at 8 h postinfection. No significant differences were noted between strains C488 and A11 (Fig. 5A) .
Moreover, the transformed human T-cell lines CB-15 (CD4ϩ) and 3C (CD8ϩ) were analyzed by orf50a RT-PCR without or with additional stimulation by 2 ng/ml TPA for 6 h. RT-PCR was performed with two different primer pairs ( Fig. 5B : upper panel, HF317/HF180; lower panel, HF317/HF318). Northern blot hybridization with an antisense riboprobe was not sufficiently sensitive to demonstrate orf50a transcripts. However, whereas background transcription was not observed, orf50a transcripts were demonstrated by RT-PCR in transformed human T cells after phorbolester stimulation.
To provide the formal proof of orf50a transcripts, RNase protection assays were performed (Fig. 5C) . A fragment of about 350 nt was specifically protected from RNase digestion of total RNA samples after hybridization with a radioactive antisense-oriented riboprobe of 976 nt. The respective band had strong intensity at 48 and 72 h postinfection. Weak transcription was confirmed for phorbolester-stimulated C488-transformed human T cells. Thus the transcript start was mapped to approximately 350 nt upstream of the splice donor site.
Differential transactivation by orf50 genes: comparison of strains A11 versus C488
The pronounced sequence divergence in the C-terminal portion of orf50b of these strains raised the question for functional consequences. We cloned and sequenced a series of C488 promoters for ORF50 target genes, which had been previously identified in the A11 system (Whitehouse et al., 1997a (Whitehouse et al., ,b, 1998a , that is, the promoter regions of orf6, orf36, orf44, and orf57. Whereas the orf6 promoters displayed only 75% nucleic acid identity, the promoters for orf36, orf44, and orf57 were highly conserved at 97, 99, or 98% identity, respectively (Table  1) .
For further analysis, we chose the divergent orf6 pro-moter and the well-conserved orf57 promoter and cloned each upstream of the cat reporter gene. The C488 promoters were generated in the form of cloned fragments homologous to the respective A11 constructs (pAWCAT2 [orf6 promoter], pORF57CAT1 [orf57 promoter]) (Whitehouse et al., 1997b (Whitehouse et al., , 1998a . C488 transactivator plasmids were constructed corresponding to the PstI (genomic orf50a and orf50b) and HincII fragments of A11 (orf50b with own promoter) as described (pAWPstI [genomic PstI fragment], pAWHincII [genomic HincII fragment]) (Nicholas et al., 1991; Whitehouse et al., 1997a) . In addition, cDNA expression plasmids for orf50a of A11 (pORF50a) (Whitehouse et al., 1997a) and C488 were used. Each respective promoter-reporter construct was cotransfected with the transactivator plasmids into OMK cells, harvested after 48 h, and assayed for CAT activity. Experiments were performed in parallel with A11-and C488-derived constructs; orf50b of A11 was confirmed to be a poor activator of heterologous viral promoters compared to orf50a, as previously described (Whitehouse et al., 1997a (Whitehouse et al., , 1998a . In contrast, the long genomic, the cDNA version (both encode orf50a and orf50b simulta- FIG. 4 . cDNAs of the orf50 region. Using gene-specific primers (HF177, HF181, HF184, HF653), 5Ј and 3Ј RACE experiments were performed. The upper three sets of cDNA clones were generated from RNA of lytically infected OMK cells, whereas the set shown below (16-23) resulted from RNA of phorbolester-stimulated, HVS-transformed, nonproductive human CD4ϩ T cells. The cDNA start and stop pos. are given with nt pos. in 488R. Whereas the specific primer defines one end of the cDNA clones, the other end is marked by the adapter primer used in the RACE protocol. Dotted lines indicate introns in the cDNA clones 1, 6, 7, 16, and 17. In clones 1 and 2, the 3Ј end of the cDNAs is marked by a polyT stretch, reflecting polyadenylated mRNA. The termini of the cDNA clones 6, 7, 11, and 12 are far downstream of orf50. SA, splice acceptor; SD, splice donor. neously), or the short genomic version of C488 orf50 alone, reproducibly showed approximately the same transactivating capability (Fig. 6 ). This suggests that, unlike in strain A11, orf50b is the major transactivating protein in C488.
DISCUSSION
HVS strains are classified into three subgroups, based on their transforming ability and terminal L-DNA sequence (Medveczky et al., 1984 (Medveczky et al., , 1989 . Even different The results of the upper panel were generated by RT-PCR with the primer combination HF317 and HF180. In the lower panel, primers HF317 and HF318 were used for RT-PCR. Below, a graph describes the coordinates of the PCR products. (C) Demonstrates orf50a transcripts by RNase protection assays. As illustrated by the graph, a radioactive antisense-oriented riboprobe was synthesized using SP6 RNA polymerase after linearization of the template plasmid with NotI. The entire riboprobe of 976 nt was shortened to a protected fragment of approximately 350 nt, which indicates the transcription start site for orf50a upstream of the splice donor site. High amounts of orf50a transcripts were seen 48 and 72 h after infection of OMK cells. Low transcript amounts were detected after phorbolester stimulation of transformed human T cells (3C, CB-15). strains of the same subgroup show some variation in their transformation-associated genes, leading to different phenotypes, e.g., in human T cells transformed with these viruses Lee et al., 1997) . Previously, no significant sequence differences have been reported for genomic regions other than the transformation-associated genes. The regions orf12 to orf25, as well as orf71/vFLIP have been shown to be highly conserved (Y13183, Knappe et al., 1997; Y13660, Kraft et al., 1998) . We were most surprised, therefore, to note the pronounced sequence divergence between the orf50 transactivator genes of HVS strains A11 and C488 (Fig. 1,  Table 1 ). In contrast to A11, C488 is able to transform human T cells in culture . However, this observation does not yet allow us to correlate orf50 genotype and transforming capability. Presently, additional orf50 alleles from 11 new virus isolates are being sequenced. A pronounced correlation between orf50 alleles and the respective virus subgroup has been noted, thus proposing an association of orf50 alleles and trans-forming phenotype (Thurau, Wittmann, and Fickenscher, unpublished observations) .
In this study, we have shown that the orf50 region is predominantly transcribed in the antisense orientation during lytic replication of HVS C488 (Figs. 3 and 4) . These antisense transcripts carry orf49, which is not yet functionally characterized. Some of these transcripts are spliced and initiated far upstream in the orf52/orf53 region. Whereas orf50a transcripts were shown at 8 h postinfection (Fig. 5A) , abundant antisense transcription was clearly delayed, starting at 24 h (Fig. 3) . It is noteworthy that the antisense transcription was observed only with strain C488. When the tailing experiment was previously performed with strain A11, only orf50 sense transcripts were detected (Whitehouse et al., 1997a) . We were also unable to detect antisense transcripts on Northern blots from A11-infected OMK cells. Since orf50 is one of only two likely viral replication regulatory genes, it may be conceivable that antisense transcription provides a regulatory mechanism at later times of lytic FIG. 6. Differential transactivation by orf50 genes of strains A11 versus C488. Transactivation studies were performed after lipofectamine transfection into OMK cells. Published plasmids for A11 genes and promoters were used (Whitehouse et al., 1997a (Whitehouse et al., ,b, 1998a ) and compared to their respective counterparts from virus strain C488. The summary of three independent experiments is shown. Standard deviation values are indicated. The genomic and cDNA orf50a constructs encode both orf50a and orf50b. Relevant differences in transactivation were not observed, when either genomic or cDNA constructs for orf50a had been transfected. Whereas orf50b of A11 was poor in activating the heterologous viral promoters, orf50a and orf50b of C488 had similar transactivating capability on the orf6 and orf57 promoters.
infection. Antisense-mediated regulation has been previously described, e.g., for the EBV gene BZLF1 and for the latency-associated transcripts of herpes simplex virus (Prang et al., 1995; Thompson and Sawtell, 1997; Sawtell et al., 1998) . Antisense transcription has also been noted for an immediate-early gene of Marek's disease virus (Cantello et al., 1994) .
We have clearly demonstrated the presence of spliced orf50 transcripts soon after lytic infection of permissive OMK cells (Figs. 5A and 5C ). Moreover, we have shown that orf50 is one of the few virus genes expressed in transformed human T cells after phorbolester stimulation ( Figs. 5B and 5C ). The genes stpC and tip, which are essential for transformation, show basal transcription and can be stongly induced by T-cell stimulation Knappe et al., 1997) . The gene orf14 is weakly expressed in transformed human T cells and is heavily induced after chemical T-cell stimulation. However, this gene is not required for transformation of human T cells . Subtractive cDNA cloning revealed transcription of two other virus genes in phorbolester-stimulated transformed human T cells, namely thymidylate synthase (ts) and orf57, besides orf50, the other known viral regulatory gene of HVS. Neither ts nor orf57 showed basal expression; transcripts were detectable only at low levels after chemical T-cell stimulation . It appears that orf50 belongs to this small group of genes which can be induced during the persistent and nonproductive infection of transformed human T cells. It is noteworthy that the two replication regulatory genes orf50 and orf57 are both included in this group. However, the induced expression of these genes in stimulated C488-transformed human T cells is not sufficient for virus reactivation, as numerous experiments have failed to detect signs of lytic replication . The block of virus replication in transformed human T cells seems to be localized downstream of the expression of the viral regulatory genes.
The EBV gene BRLF1, a homolog to HVS orf50, encodes the R transactivator (Rta), which is sufficient for disruption of latency in EBV-permissive B cells and epithelial cells (Zalani et al., 1996; Ragoczy et al., 1998) . Furthermore, the human ␥ 2 -herpesvirus type 8 (HHV-8/ KSHV) encodes a homologous transactivator, which was assigned to the immediate-early phase and induces lytic replication in transformed B cells (Lukac et al., 1998 (Lukac et al., , 1999 Sun et al., 1998 Sun et al., , 1999 Zhu et al., 1999) . The function of the HVS orf50 has been extensively studied using the prototype strain A11. Initially, transactivation of the orf6 promoter by a genomic A11 fragment harboring orf50 was noted (Nicholas et al., 1991) . Subsequently, two variants of orf50 were characterized: orf50a is a spliced transcript with early expression during virus replication, and orf50b is a shorter, unspliced transcript with delayed transcription. The spliced transcript of A11 was much more potent than the shorter construct in activating the orf6 and orf57 promoters (Whitehouse et al., 1997a (Whitehouse et al., , 1998a . The target sequence for the transactivator was narrowed down to a 38-bp fragment within this promoter and a consensus response motif CCN 9 GG was suggested (Whitehouse et al., 1997b) . The other regulatory gene of HVS, orf57, is homologous to IE63/ICP27 of herpes simplex virus and to BMLF1 of EBV; orf57 has been shown to repress the transactivating capability of the spliced orf50a on a posttranscriptional level, whereas the transcript levels of orf50b were slightly enhanced by orf57 (Whitehouse et al., 1998b) . Unlike orf50b, orf50a was capable of transactivating orf57 expression (Whitehouse et al., 1998a) .
In contrast to these results, similar transactivation levels on the orf6 and orf57 promoters were noted for the C488-derived transactivators, when either the long genomic fragment or the cDNA version was used (which encode both orf50a and orf50b), or when the short genomic orf50b fragment was used (Fig. 6) . The transactivation function itself seemed not to be altered between both virus strains. Correspondingly, the C-terminal activation domain of ORF50 was well conserved with some conservative amino acid exchanges when compared to the respective motifs of HVS A-11 or even to HHV8 Lukac et al., 1999) . Since A11-ORF50b had been shown to be a poor transactivator, a mechanism of competitive downregulation of target genes at delayed times of infection had been postulated (Whitehouse et al., 1997a (Whitehouse et al., , 1998a . This type of negative regulation is unlikely for strain C488, in which ORF50b is fully functional and in which ORF50 function should not be switched off by ORF57-mediated splice regulation and downregulation of ORF50a. This would lead to the hypothesis that transactivation by the R product of C488 was mainly carried out by ORF50b independently of ORF57-mediated downregulation (Fig. 7) . Thus, ORF50a would not critically contribute to the observed transactivation, at least in strain C488. Since the replication kinetics of strains A11 and C488 are indistinguishable, we assume that downregulation of orf50 by orf57 may not be the critical point for HVS C488 replication. This supports the idea that transactivation by orf50 forms an early step in induction of lytic virus replication prior to orf57 function, a mechanism which is obviously impaired in HVS C488-transformed human T cells.
MATERIALS AND METHODS
Cloning of C488 genes
Virion DNA of strain C488 was digested with the restriction enzymes HindIII and XbaI in parallel reactions. The resulting library of overlapping fragments was cloned into the Bluescript KSϩ vector (Stratagene) . After terminal sequences of the fragments had been obtained, a series of plasmids rep-resenting the orf50 region were selected and sequenced on both strands by the dye deoxy terminator method (ABI). The resulting sequence of 3171 nucleotides was designated 488R.
The coding part of the spliced orf50a cDNA from C488 was amplified by RT-PCR using the oligonucleotide primers HF317 (ATG-ACA-CAC-AAG-CCT-G, 5Ј primer, nt pos. 163 in 488R) and HF377 (GCT-TTA-TTC-ATC-AGT-TAC-TAA-ATC, 3Ј primer, pos. 2664 in 488R, reverse orientation [rev.]). A genomic fragment of orf50a, including its own promoter similar to the published PstI fragment of strain A11 (Nicholas et al., 1991) , was amplified using HF166 (GGA-GCA-TAA-AAT-AAA-GCC-AAC-AG, 5Ј) and HF213 (GTC-AAT-GCT-ATG-TGC-TTG-TAA-TAT-C, 3Ј, rev.). Both primers are situated outside of the 488R sequence and were derived from short sequences obtained from neighboring plasmid clones. In analogy to the published HincII fragment of A11 (Nicholas et al., 1991) , the genomic fragment representing the unspliced orf50b including its own promoter was prepared with HF280 (GGT-TGA-CTC-AGC-TTA-GG, 5Ј orf50b, pos. 982 of 488R) and HF281 (TTA-GAA-TAT-CTG-CTA-TAT-TAG-G, 3Ј orf50b, pos. 2880 of 488R, rev.). PCR fragments were generated either with KlenTaq (Clontech) or with Pwo polymerase (Roche) and subsequently cloned into pCR2.1 or pCR-Blunt vectors (Invitrogen). The orf50a cDNA fragment was also subcloned into the expression vector pcDNA3 (Invitrogen).
The orf6 promoter region of C488 was amplified with HF265 (AAG-CTT-GAA-AAA-CCA-AAA-GTT-GCT-AAT-G, 5Ј) and HF253 (CCG-CTG-CAG-TGT-TAG-ATG-TGG-ATG-CTT-TGA-GAG, 3Ј, rev.), the orf36 promoter with HF279 (GTC-GAC-GTG-AAG-ACA-CAG-TCA-AG, 5Ј) and HF267 (TCT-AGA-GCC-ATT-GTT-GAG-AGA-TTC, 3Ј, rev.), the orf44 promoter with HF263 (AAG-CTT-TCT-ACT-GCT-ATA-TGC-TTG, 5Ј) and HF264 (TCT-AGA-TAG-TTC-TGC-CAT-TAT-TCC, 3Ј, rev.), and the orf57 promoter with HF328 (AAG-CTT-CAG-ATA-ATA-TCC-ATT-TTG-TCC-CAG, 5Ј) and HF327 (AAG-CTT-GGC-AGT-TGT-TCA-CCA-TAG, 3Ј, rev.).
Plasmid clones of all PCR products were sequenced and found to be identical to the respective DNA sequence derived from the plasmid library . The orf6 and orf57 promoters were inserted into the pCAT-Basic reporter vector (Promega).
The nucleotide sequences of HVS C488 described in this report are available under accession numbers AJ131935 (488R, orf50 region), AJ131936 (orf6 promoter), AJ131937 (orf36 promoter), AJ131938 (orf44 promoter), and AJ131939 (orf57 promoter) in the EMBL sequence library.
Transcript analysis
Total cellular RNA was prepared by the acidic phenol method (Chomczynski and Sacchi, 1987) . Polyadenylated RNA was purified from total RNA with oligo-dT Dynabeads (Dynal). Reverse-transcription was performed with Superscript II (Gibco) and either random hexamer or oligo-dT primers. To demonstrate orf50a transcription, RT-PCR was performed using the following primers: HF317 (ATG-ACA-CAC-AAG-CCT-G, 5Ј, pos. 163 in 488R), HF180 (CTG-CAA-TTT-GTA-GGC-ACT-C, 3Ј, pos. 1296 in 488R, rev.), HF182 (GTC-CCA-TTA-ACA-CGC-TTT-TTT-C, 3Ј, pos. 1623 in 488R, rev.), HF318 (CTA-AAG-TTG-TAG-ATA-CTA-TTC-C, 3Ј, pos. 1689 in 488R, rev.), HF463 (CAA-TGA-CAC-ACA-AGC-TTG, 5Ј, pos. 69876 in A11), and HF464 (TCC-CAT-TAA-CAC-ACT-TTT-TTC, 3Ј, pos. 71338 in A11, rev.). As an internal control, RT-PCR for glyceroyl aldehyde phosphate dehydrogenase (gapdh) was performed with HF147 (GCA-GGG-GGG-AGC-CAA-AAG-GG, 5Ј) and HF148 (TGC-CAG-CCC-CAG-CGT-CAA-AG, 3Ј, rev.).
Experiments for the rapid amplification of cDNA ends (RACE) were performed with the Marathon kit (Clontech) and with the primers HF177 (CAC-CAT-TCG-TAA-AAT-GCA-CC, pos. 364 in 488R), HF181 (CAT-ACA-ACG-CCT-TGT-CTA-C, pos. 1472 in 488R), HF184 (AAA-GGG-ATG-TGA-TGA-GGA-G, pos. 2134 in 488R, rev.), and HF653 FIG. 7. Comparative model of gene regulation in the virus strains A11 and C488. The figure compares the published observations for strain A11 (Whitehouse et al., 1997a (Whitehouse et al., ,b, 1998a with the results from this study on virus strain C488. Orf50 seems to play a more central role in the regulation of virus gene regulation, since the mechanism of transactivation blockade by ORF50b is not active in strain C488. Stimulatory effects are indicated as arrows, inhibitory functions as dashed lines.
(CCC-TAT-GTC-TTC-AAG-TTC-TAC-ACT-ATC-AG, pos. 2611 in 488R, rev.). Northern blots were hybridized either with a random-primed double-stranded orf50b DNA probe or with single-stranded RNA probes prepared by in vitro transcription of the orf50b plasmid with SP6 or T7 RNA polymerase. For RNase protection experiments, a template plasmid was generated by cloning an 822-bp PCR product exactly upstream of the orf50a splice donor site into pCRII (Invitrogen). A radioactive antisense riboprobe of 976 nt was generated using SP6 RNA polymerase, 32 P-UTP, and the template plasmid after NotI linearization. Total cellular RNA (40 g each) was hybridized to the riboprobe (250,000 cpm in 10 l) at 37°C. After digestion with the RNases A and T1, the protected fragments were purified and visualized by autoradiography after separation on a sequencing gel. In vitro transcription and translation assays were performed in the presence of 35 S-methionine, using T7 polymerase and a reticulocyte lysate kit from Promega.
Cell culture and transfections
Permissive owl monkey kidney cells (OMK) were cultivated and infected with HVS according to standard protocols . OMK cells were transfected in triplicates with transactivator and reporter plasmids (2 g each), using lipofectamine (Gibco) according to published protocols (Whitehouse et al., 1997a) . The transactivation experiments were repeated twice and yielded similar results. CAT enzyme activity was measured by quantitative autoradiography of silica chromatography plates. The T-cell lines CB-15 (CD4ϩ; Biesinger et al., 1992) and 3C (CD8ϩ; Fickenscher et al., 1996) were grown in the presence of interleukin-2 under standard conditions .
